Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Anagnostics Enters Sales Cooperation with Analis S.A.

Published: Monday, December 10, 2012
Last Updated: Monday, December 10, 2012
Bookmark and Share
Company enters cooperation for Belgium and Luxembourg.

The Belgian company is specialized on clinical diagnostics and distributes Anagnostics’ innovative laboratory in the areas of drugs of abuse screening, personalized medicine (oncology) and sepsis diagnostics.

Since this summer Analis S.A. from Suarlée (near Namur) offers Anagnostics’ diagnostic products for drugs of abuse screening and personalized medicine.

In the coming months the sales portfolio will be enlarged by tests supporting the diagnosis and therapy of sepsis.

Analis and Anagnostics aim to serve hospitals in the Belux countries by offering truly innovative products and first class service.

“Analis is specialized on clinical diagnostics for a broad and loyal customer base and emphasizes first class support and advice of customers. Therewith Analis is the ideal partner for the distribution of our laboratory tests in Belgium and Luxembourg”, comments Christoph Reschreiter, CEO of Anagnostics Bioanalysis GmbH.

Guy Stukkens, CEO of Analis S.A. is looking forward to the sales cooperation: “We clearly see the trend towards more specific as well as more targeted and faster diagnostics, which is offered by multiplexed diagnostics. Anagnostics reacted on this need perfectly well. With the hyborg device and the test portfolio Anagnostics offers good market opportunities. The fast and efficient testing of drugs of abuse consumption ensures access to therapy institutions. The simple and highly sensitive tests in personalized medicine are particularly advantageous for small and medium sized pathologies, because cost efficiency is ensured even with low sample numbers.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Anagnostics and Molzym Form Strategic Alliance Fighting Sepsis
Agreement and partnership to commonly develop hybcell Pathogens DNA.
Monday, July 09, 2012
Vela Laboratories and Anagnostics Enter Strategic Partnership
Partnership to offer hybcell technology to biotech and pharma customers under GMP conditions.
Thursday, May 24, 2012
Ramcon A/S (Denmark) Distributes and Supports Anagnostics Products
Ramcon covers the Northern European countries and serves customers in Denmark, Sweden, Norway, Finland and Iceland with a highly specialized sales force.
Thursday, April 12, 2012
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos